Luxury infographic: GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles
Board-ready guide charts global Quantum Computing (QC) market and pharma pilots, giving boards actionable governance, security and talent frameworks.
Quantum plus AI is a transformative leap—enabling precision medicines to reach patients faster, cheaper, and more equitably.— Dr. Aisha Rahim, MD – Co-Chair AI Governance, Johns Hopkins Health Plans
WASHINGTON D.C, MD, UNITED STATES, May 27, 2025 /
EINPresswire.com/ -- Global Board Advisors Corp (GBAC) today released “
Quantum Healthcare 2025: The Executive Blueprint – Seizing Strategic Advantage in the New Era of Medicine.” Co-authored by Prof. Yusuf A. Azizullah, GBAC CEO, and Dr. Aisha Rahim, MD, FHM, Medical Executive at Johns Hopkins Health Plans and Co-Chair of its Artificial Intelligence (AI) Governance Council, the 60-page report equips life-science boards and investors for healthcare’s quantum leap.
Governments have already earmarked US $40 billion-plus for quantum-health programmes across 30 nations, highlighting the sector’s accelerating momentum.
Pharma-Focused Highlights
US $3.2 billion quantum-drug-discovery market by 2030 (42 % CAGR).
50–70 % faster R&D cycles – hybrid Quantum Computing (QC) + AI slashes hit-to-lead and toxicology loops.
Flagship pilots now live
Cleveland Clinic – IBM Discovery Accelerator: quantum cardiac-drug pipeline
Google DeepMind / Isomorphic Labs + Eli Lilly: QC-AI small-molecule design
Merck – Amgen – QuEra: Quantum Reservoir Computing for “small-data” trial prediction
St Jude Children’s + University of Toronto + D-Wave: cracking KRAS “undruggable” oncology target
Supply-chain upside – quantum optimisation for cold-chain routing and active-pharmaceutical--ingredient yield, while GBAC’s Health-Equity-by-Design™ checklist ensures breakthroughs reach diverse patient groups.
Dr. Aisha Rahim: “Quantum plus AI is a transformative leap—enabling precision medicines to reach patients faster, cheaper, and more equitably.”
Prof. Azizullah: “Winning in the quantum-AI era isn’t about chasing proofs-of-concept; boards must fund scaled pilots, hard-wire post-quantum security, and build cross-disciplinary talent.”
Global & Regional Momentum
United States – Google, IBM, Microsoft, IonQ driving QC hardware; Pfizer, Moderna and Amgen running quantum pipeline pilots.
China – Baidu QianShi, Huawei Cloud, SpinQ lead patent filings; Sinopharm and WuXi AppTec invest in quantum assay design.
European Union / UK – Quantinuum, Pasqal, IQM partner with Merck KGaA, Boehringer Ingelheim, AstraZeneca.
United Arab Emirates / GCC – Technology Innovation Institute building a 54-qubit system; G42 Healthcare and Mubadala exploring quantum supply-chain models.
Funding snapshot – China (~ US $15 B), EU (> US $10 B), United States (~ US $7 B) and new Gulf programmes (UAE, Saudi) anchor the > US $40 B public-funding pool.
Governance & IP Security
GBAC introduces four proprietary board tools:
IGRQ Nexus™ – aligns Investor goals, Governance maturity & Quantum-risk appetite.
Board-Level Quantum Governance Charter – template for Audit/Risk or Tech-Quantum committees.
Post-Quantum Cryptography (PQC) Transition Roadmap – shields pharma intellectual property from “Harvest-Now-Decrypt-Later” attacks; GBAC urges 75 % of U.S. hospitals to complete PQC plans by 2027.
QCOps™ Maturity Ladder – five stages for scaling pilots into compliant production workloads.
Board imperatives
• Hold quarterly quantum-literacy briefings
• Fund QRA + PQC migrations by FY-26
• Launch two QC-AI pilots (oncology, cardiometabolic)
• Report Health-Equity KPIs inside ESG filings
Invitation-Only Executive Briefings
Dubai – 28 May 2025 | InterContinental Dubai Festival City – focus on Gulf sovereign-fund strategy and pharma alliances.
Washington D.C. – 10 June 2025 | Salamander DC – focus on U.S.–China competition, Milken-style policy dialogue, NIH/FDA engagement.
RSVP: Chad Clark – chad@globalboardadvisors.com | +1 571-277-0642
Download the Blueprint
https://boardroomeducation.com/quantum-healthcare-2025 (includes a one-page pharma-use-case infographic)
About GBAC / BoardroomEducation.com
GBAC is the only board-governance firm globally recognised as an AACSB Business Education Alliance member. Through BoardroomEducation.com, GBAC advises Global 1000 boards, sovereign wealth funds and life-science leaders on AI, quantum computing and Environmental-Social-Governance (ESG) oversight.
Media Contact
Chad Clark, Managing Director
chad@globalboardadvisors.com • +1 571-277-0642
Chad Clark
Global Board Advisors Corp (GBAC) – BoardroomEducation.com
+1 571-277-0642
email us here
Visit us on social media:
LinkedIn